1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NORD Rare Disease Research Grants Program is sponsored by National Organization for Rare Disorders (NORD). NORD Research Grants provide seed grants to academic scientists for translational or clinical studies that further the development of potential new diagnostics or treatments of rare diseases. The grants are competitive and international.
NORD accepts gifts restricted to research grant funds in support of a specific rare disease or to NORD's general research grant fund. Awards are based solely on scientific merit. This program has previously funded research for Homocystinuria and related disorders.
Get alerted about grants like this
Get emailed when new opportunities from “National Organization for Rare Disorders (NORD)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Academic scientists for translational or clinical studies. Open globally. All individuals holding a faculty-level appointment at an academic institution or a senior scientific position at a non-profit institution or foundation are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows varies (minimum of $62,500 USD to fund one grant for a specific rare disease, up to $30,000 or $50,000 for specific current opportunities listed). Verify award ceilings, matching requirements, and allowable costs in the official notice.
NORD Rare Disease Research Grants Program is funded by National Organization for Rare Disorders (NORD). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
RareCare Patient Assistance Programs is a suite of programs from the National Organization for Rare Disorders (NORD) that funds financial assistance for individuals living with rare diseases. Since 1987, NORD has offered programs covering life-saving medications, insurance premium and co-pay assistance, diagnostic testing, travel assistance for clinical trials or specialist consultations, caregiver respite, emergency relief, and educational support. Programs vary by rare disease and may be open for applications, waitlisting, or closed depending on current funding. Eligible applicants are individuals diagnosed with qualifying rare diseases who cannot otherwise afford critical treatments or care.
NORD Rare Disease Research Grant Program is sponsored by National Organization for Rare Disorders (NORD). NORD's Research Grants provide seed funding to academic scientists for translational or clinical studies that advance the development of potential new diagnostics or treatments for rare diseases. The program prioritizes diseases with few other funding sources. While primarily for academic scientists, small businesses collaborating with eligible institutions may find this relevant.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
On June 2, 2026, the Department of Energy's Office of Critical Minerals and Energy Innovation selected two demonstration-scale facilities — Phoenix Tailings (with MIT and the University of Minnesota) for $66 million, and the Colorado School of Mines (with ElementUSA, PNNL, Principal Mineral, and Rare Earth Technologies Inc.) for the balance — under the Rare Earth Elements Demonstration Facility Program. Both projects pull rare earths from industrial waste — red mud at the Gramercy refinery in Louisiana, and a mix of mine and refining tailings elsewhere. Here is what the selections tell researchers, small businesses, and downstream magnet customers about where DOE thinks the chokepoint actually is, and what to do before the next demonstration-scale solicitation opens.
Read articleOn May 19, the Department of Energy's Office of Critical Minerals and Energy Innovation announced 19 selections under FOA 3105 — two pilot-scale facilities for magnesium and rare-earth separation, and 17 technology development projects spanning lithium, cobalt, nickel, graphite, silicon, and manganese. Here is what the selection list tells researchers and small businesses about where DOE wants the supply chain in 18 months — and where the next solicitations will go.
Read articleDOE's Critical Minerals and Materials Accelerator funds lithium extraction, rare earth recycling, and semiconductor-grade refining. Staggered deadlines run through July 2026.
Read article